EAM
BSX icon

Eschler Asset Management’s Boston Scientific BSX Stock Holding History

Eschler Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,690
Closed -$933K – 71
2025
Q2 		$933K Buy
+8,690
New +$879K 0.7% 31

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Eschler Asset Management's BSX Position: Q3 2025 in Review

Eschler Asset Management sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 8,690 shares — an estimated $933K sold.

Eschler Asset Management first reported a position in BSX in Q2 2025 and held it in 1 quarter. The position peaked at $933K in Q2 2025. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Eschler Asset Management reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
  • Eschler Asset Management sold 8,690 Boston Scientific shares in Q3 2025, an estimated $933K.
  • Eschler Asset Management first reported a position in Boston Scientific in Q2 2025 and held it in 1 quarter.
  • Eschler Asset Management's Boston Scientific position peaked at $933K in Q2 2025.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Eschler Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.